以岭药业 (002603)

SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD

ASZ

Tags

CSI 200 IndexGeneric DrugsInnovative DrugsFace Mask ProtectionGene ConceptHelicobacter PyloriEmerging Markets IndexSmart HealthcarePrivate Enterprises 100 IndexHigh-Performing StocksShenzhen Main Board 50 IndexShenzhen ConnectSZSE 100 IndexSZSE 300 IndexSZSE Growth IndexPharma & BiotechChinese Med. IISZSE Defensive 50 IndexConsumer Services IndexSME Board Emerging IndexSZSE Medicine Equal Weight IndexBrand Engineering IndexSME 100 Return IndexSZSE 100 Equal Weight IndexEqual Weight 90 IndexZhongchuang Equal Weight IndexShenzhen A-Share Pharmaceutical IndexBOC International CSI 300 ESG IndexCSI 100 Low Volatility IndexCSI All-share Pharmaceutical Sector IndexSZSE Emerging Industries IndexZhongchuang Growth IndexSZSE 1000 IndexSME Board Equal Weight IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCSI 300 Equal Weight IndexCSI 300 ESG IndexLarge & Mid-cap IndexCNI 1000 IndexXingyin Wealth Management Balanced 300 IndexCS Beijing-Tianjin-Hebei IndexCR Foundation IndexCSSW Silk Road IndexExcellent Performance Strategy IndexZhongchuang Value IndexInfluenza/MaskNew Virus PreventionCOVID-19 PreventionGene SequencingFTSE Russell ConceptSecurities Firms Heavy HoldingsSME Board Responsibility IndexCSI 300 Non-cyclical IndexPension Industry IndexSME Board Composite IndexPublic Health IndexSZSE Selected IndexCSI 300 Shenzhen Market IndexZhongchuang 100 Return IndexSZSE Technology IndexEmerging Industries Composite IndexSZSE 100 Return IndexManufacturing IndexSZSE ChiNext 100 IndexSustainable Development IndexCSI 300 Growth IndexSecurities Times Value 100 IndexSZSE Pharmaceutical IndexDividend Quality IndexCSI 800 IndexCS Pharmaceutical TI Index100 Performance IndexCSI 300 Preferred IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexCNI 300 IndexCCTV 500 IndexCSI 300 USD (CNH) IndexSZSE Private Enterprises IndexCS Pharmaceutical Innovation IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexPharmaceutical Sub-sector IndexSZSE Low Volatility IndexCSI All-share Pharmaceutical IndexCSI 300 USD IndexSZSE Pharmaceutical 50 IndexSME Board Low Volatility IndexSZSE 300 Equal Weight IndexCSI Pharmaceutical IndexCSI 500 Equal Weight IndexCSI 800 Pharmaceutical IndexSZSE Component Index Equal WeightCS Biomedicine IndexPharmaceutical & Health 100 IndexCSI 300 Value Stable IndexCSI 300 Pharmaceutical IndexSME Board Performance IndexHigh Dividend Yield Strategy IndexCSI 700 IndexSME Board Dividend IndexAH Economic Blue-chip IndexMid-small Cap IndexSZSE Fundamental 200 IndexCSI 500 IndexPharmaceutical 50 IndexZhongchuang Low Volatility IndexPharmaceutical 50 Strategy IndexSZSE 200 Return IndexSZSE 200 IndexMid-cap Low Volatility IndexCICC 300 IndexZhongchuang 400 IndexESG 300 IndexChina Economic Index GDPJuchao Mid-cap IndexSZSE 500 IndexFundamental 600 IndexCSI 500 ESG Index

K-Line Chart

No K-line data available

Company NameShijiazhuang Yiling Pharmaceutical Co., Ltd.
Listing Date2011-07-28
Issue Price34.56RMB
Registered Capital167070.537610k RMB
Legal RepresentativeWu Xiangjun
Registered AddressNo. 238 Tianshan Street, High-Tech Industrial Development Zone, Shijiazhuang City, Hebei Province
IndustryTraditional Chinese Medicine II
Main BusinessResearch, development, production, and sales of pharmaceuticals
Company ProfileThe company was established on August 28, 2001, through the overall restructuring of Shijiazhuang Yiling Pharmaceutical Co., Ltd. It is primarily engaged in the research, development, production, and sales of Chinese patent medicines. It is a national high-tech enterprise and possesses an enterprise technology center recognized by five national ministries and commissions.

Stock Details

1. Key Indicators

  • Total Shares(W): 167070.54
  • Circulating A-Shares(W): 137684.67
  • Earnings Per Share(RMB): 0.5988
  • Net Assets Per Share(RMB): 6.4068
  • Operating Revenue(W RMB): 586760.31
  • Total Profit(W RMB): 116963.54
  • Net Profit Attributable to Parent(W RMB): 100040.47
  • Net Profit Growth Rate(%): 80.33
  • Weighted Return on Equity(%): 9.3400
  • Operating Cash Flow Per Share(RMB): 0.7650
  • Undistributed Profit Per Share(RMB): 3.4593
  • Capital Reserve Per Share(RMB): 1.3909

2. Main Business

The main business covers:

  • R&D, production and sales of patented innovative traditional Chinese medicine

3. Company Basic Information

  • Company Name: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  • Listing Date: 2011-07-28
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 238 Tianshan Street, High-tech Industrial Development Zone, Shijiazhuang City, Hebei Province
  • Website: www.yiling.cn
  • Company Profile: According to the resolution of Yiling Co., Ltd.'s shareholders' meeting and approved by the Hebei Provincial People's Government's "Reply on Approving the Change and Establishment of Shijiazhuang Yiling Pharmaceutical Co., Ltd." (Ji Gu Ban [2001] No. 90), Yiling Co., Ltd. was restructured and established as Shijiazhuang Yiling Pharmaceutical Co., Ltd. on August 28, 2001, using the audited net asset value of 79,866,655.57 yuan as of May 31, 2001, converted into 79,866,000 shares of the company, with the remaining 655.57 yuan as capital reserve. Zhongqin Wanxin Certified Public Accountants issued the "Capital Verification Report" (2001) Qin Xin Yan Zi No. 08021. On the same day, the company obtained the "Business License" issued by the Hebei Provincial Administration for Industry and Commerce, with registration number 1300001001986.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Yiling Pharmaceutical Technology Co., Ltd. General Legal Person 52677.60 38.26
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 2570.40 1.87
3 CSI 500 Exchange Traded Open-End Index Securities Investment Fund Fund 1213.96 0.88
4 Changxin Jinli Trend Hybrid Securities Investment Fund Class A Fund 595.00 0.43
5 Ping An Fund - Ping An Life Insurance Company of China, Ltd. - Dividend - Individual Insurance Dividend - Ping An Life - Ping An Fund Equity Entrusted Investment No. 2 Single Asset Management Plan Asset Management Plan 536.40 0.39
6 ChinaAMC CSI Traditional Chinese Medicine Exchange Traded Open-End Index Securities Investment Fund Fund 521.06 0.38
7 Qianhai Kaiyuan Traditional Chinese Medicine Research Selected Stock Initiated Securities Investment Fund Class A Fund 355.21 0.26
8 Penghua CSI Traditional Chinese Medicine Exchange Traded Open-End Index Securities Investment Fund Fund 199.07 0.14
9 Jiutai Jiurui Quantitative Stock Securities Investment Fund Class A Fund 39.85 0.03
10 Changxin Healthcare Industry Flexible Allocation Hybrid Securities Investment Fund (LOF) Class A Fund 19.23 0.01

5. Concept Sectors

  • Biological Vaccine
  • Smart Wearables
  • Pension Concept
  • Gene Concept
  • Smart Healthcare
  • Generic Drugs
  • Mask Protection
  • Helicobacter Pylori
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • SME 100
  • SZSE 300
  • SME 300

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information